Get started
Author

Melanie Hussong

Observed names: Hussong, Melanie A., M Hussong, Melanie A. Hussong
ORCID: 0009-0003-3014-1808
Observed ORCID: 0009-0003-3014-1808
OpenAlex ID: A5000253588
Systematic assessment of commercially available low-input miRNA library preparation kits
2019 · Fatima Heinicke, Xiangfu Zhong, et al. · RNA Biology · 46
PDF
Pre‐analytical factors affecting the establishment of a single tube assay for multiparameter liquid biopsy detection in melanoma patients
2020 · Svenja Schneegans, Lelia Lück, et al. · Molecular Oncology · 35
PDF
Increased antitumor efficacy of PD-1-deficient melanoma-specific human lymphocytes
2020 · Lucine Marotte, Sylvain Simon, et al. · Journal for ImmunoTherapy of Cancer · 35
PDF
Differential impact of genetic deletion of TIGIT or PD-1 on melanoma-specific T-lymphocytes
2024 · Gwenann Cadiou, Tiffany Beauvais, et al. · OncoImmunology · 8
PDF
148: Increased nuchal translucency and normal karyotype: value of additional testing
2013 · Jaclyn Coletta Lucas, Elizabeth Kramer Dugan, et al. · American Journal of Obstetrics and Gynecology · 2
Abstract 5596: Impact of blood collection tubes on CTC-, ctDNA- and miRNA recoveries in malignant melanoma patients
2018 · Svenja Schneegans, Lelia Lück, et al. · Cancer Research · 1
Abstract P4-12-01: Characterizing the clinical presentation of individuals with pathogenic variants in a breast/ovarian cancer gene panel
2015 · Erica Vaccari, Lauren Yackowski, et al. · Cancer Research · 1
Intercepting Molecular Relapse in Breast Cancer: The SURVIVE HERoes Study has started Patient Recruitment
2026 · H Schäffler, K Pfister, et al. · Geburtshilfe und Frauenheilkunde
Exploration of tumor-informed ctDNA detection and dynamics in a real-world cohort of colorectal cancer patients from the MD Anderson Cancer Center.
2026 · Christopher Gareth Smith, Kathryn Aziz, et al. · Journal of Clinical Oncology
Interception of molecular relapse in breast cancer: The SURVIVE HERoes study (NCT06643585).
2026 · Wolfgang Janni, Thomas W. P. Friedl, et al. · Journal of Clinical Oncology
The SURVIVE study: Re-evaluating follow-up in early breast cancer.
2026 · Sophia T. Huesmann, Thomas W. P. Friedl, et al. · Journal of Clinical Oncology
Intercepting Molecular Relapse in Breast Cancer: The SURVIVE HERoes Study has started Patient Recruitment
2026 · K Pfister, TW P Friedl, et al. · Senologie - Zeitschrift für Mammadiagnostik und -therapie
Die SURVIVE – Studie (NCT05658172): Die aktuelle Brustkrebsnachsorge auf dem Prüfstand
2026 · S T Huesmann, TW P Friedl, et al. · Senologie - Zeitschrift für Mammadiagnostik und -therapie
Systematic assessment of commercially available low-input miRNA library preparation kits
2019 · Heinicke, Fatima, Xiangfu Zhong, et al. · Figshare
Abstract 1845: Development of a quantitative targeted RNA-Seq methodology for use in differential gene expression analysis
2016 · Eric Lader, Melanie Hussong, et al. · Cancer Research
Abstract P4-12-05: Individuals with more than one pathogenic variant: Rationale for considering multi-gene panel testing for cancer susceptibility
2015 · Rachel Nusbaum, Lisa Susswein, et al. · Cancer Research
Works count: 16
Citation count: 128
H-index: 4
I10-index: 3
Year
Topic
Type